Search

Your search keyword '"Curran, Dominic"' showing total 20 results
Start Over Author "Curran, Dominic"
20 results on '"Curran, Dominic"'

1. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study

Author

Yau, Thomas, Kaseb, Ahmed, Cheng, Ann-Lii, Qin, Shukui, Zhu, Andrew X, Chan, Stephen L, Melkadze, Tamar, Sukeepaisarnjaroen, Wattana, Breder, Valery, Verset, Gontran, Gane, Edward, Borbath, Ivan, Rangel, Jose David Gomez, Ryoo, Baek-Yeol, Makharadze, Tamta, Merle, Philippe, Benzaghou, Fawzi, Milwee, Steven, Wang, Zhong, Curran, Dominic, Kelley, Robin Kate, and Rimassa, Lorenza

Published
2024
Full Text
View/download PDF

2. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

Author

Agarwal, Neeraj, McGregor, Bradley, Maughan, Benjamin L, Dorff, Tanya B, Kelly, William, Fang, Bruno, McKay, Rana R, Singh, Parminder, Pagliaro, Lance, Dreicer, Robert, Srinivas, Sandy, Loriot, Yohann, Vaishampayan, Ulka, Goel, Sanjay, Curran, Dominic, Panneerselvam, Ashok, Schwickart, Martin, Choueiri, Toni K, and Pal, Sumanta

Published
2022
Full Text
View/download PDF

3. CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Author

Neal, Joel, Pavlakis, Nick, Kim, Sang-We, Goto, Yasushi, Lim, Sun Min, Mountzios, Giannis, Fountzilas, Elena, Mochalova, Anastasia, Christoph, Daniel C., Bearz, Alessandra, Quantin, Xavier, Palmero, Ramon, Antic, Vladan, Chun, Elaine, Edubilli, Tirupathi Rao, Lin, Ya-Chen, Huseni, Mahrukh, Ballinger, Marcus, Graupner, Vilma, and Curran, Dominic

Published
2024
Full Text
View/download PDF

6. Cabozantinib (C) in combination with atezolizumab (A) in urothelial carcinoma (UC): Results from Cohorts 3, 4, 5 of the COSMIC-021 study.

Author

Pal, Sumanta K., primary, Agarwal, Neeraj, additional, Singh, Parminder, additional, Necchi, Andrea, additional, McGregor, Bradley Alexander, additional, Hauke, Ralph J., additional, Powles, Thomas, additional, Suárez, Cristina, additional, Van Herpen, Carla M.L.-, additional, Vaishampayan, Ulka N., additional, Sudhagoni, Ramu, additional, Curran, Dominic, additional, Andrianova, Lana, additional, and Loriot, Yohann, additional

Published
2022
Full Text
View/download PDF

7. Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts 7 and 20 of the COSMIC-021 study.

Author

Neal, Joel W., primary, Santoro, Armando, additional, Viteri, Santiago, additional, Ponce Aix, Santiago, additional, Fang, Bruno, additional, Lim, Farah Louise, additional, Gentzler, Ryan D., additional, Goldschmidt, Jerome H., additional, Khrizman, Polina, additional, Massarelli, Erminia, additional, Patel, Shiven B., additional, Puri, Sonam, additional, Sudhagoni, Ramu, additional, Scheffold, Christian, additional, Curran, Dominic, additional, and Felip, Enriqueta, additional

Published
2022
Full Text
View/download PDF

8. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

Author

Pal, Sumanta K., primary, McGregor, Bradley, additional, Suárez, Cristina, additional, Tsao, Che-Kai, additional, Kelly, William, additional, Vaishampayan, Ulka, additional, Pagliaro, Lance, additional, Maughan, Benjamin L., additional, Loriot, Yohann, additional, Castellano, Daniel, additional, Srinivas, Sandy, additional, McKay, Rana R., additional, Dreicer, Robert, additional, Hutson, Thomas, additional, Dubey, Sarita, additional, Werneke, Scott, additional, Panneerselvam, Ashok, additional, Curran, Dominic, additional, Scheffold, Christian, additional, Choueiri, Toni K., additional, and Agarwal, Neeraj, additional

Published
2021
Full Text
View/download PDF

9. Cabozantinib in combination with atezolizumab in urothelial carcinoma previously treated with platinum-containing chemotherapy: Results from cohort 2 of the COSMIC-021 study.

Author

Pal, Sumanta K., primary, Agarwal, Neeraj, additional, Loriot, Yohann, additional, Suarez Rodriguez, Cristina, additional, Singh, Parminder, additional, Vaishampayan, Ulka N., additional, Mcilvaine, Elizabeth, additional, Curran, Dominic, additional, Castellano, Daniel, additional, and Necchi, Andrea, additional

Published
2020
Full Text
View/download PDF

10. Cabozantinib in combination with atezolizumab in non-small cell lung cancer (NSCLC) patients previously treated with an immune checkpoint inhibitor: Results from cohort 7 of the COSMIC-021 study.

Author

Neal, Joel W., primary, Lim, Farah Louise, additional, Felip, Enriqueta, additional, Gentzler, Ryan D., additional, Patel, Shiven B., additional, Baranda, Joaquina, additional, Fang, Bruno, additional, Squillante, Christian Michael, additional, Simonelli, Matteo, additional, Werneke, Scott, additional, Curran, Dominic, additional, and Ponce Aix, Santiago, additional

Published
2020
Full Text
View/download PDF

11. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study.

Author

Agarwal, Neeraj, primary, Loriot, Yohann, additional, McGregor, Bradley Alexander, additional, Dreicer, Robert, additional, Dorff, Tanya B., additional, Maughan, Benjamin Louis, additional, Kelly, William Kevin, additional, Pagliaro, Lance C., additional, Srinivas, Sandy, additional, Squillante, Christian Michael, additional, Vaishampayan, Ulka N., additional, Wang, Evelyn W., additional, Curran, Dominic, additional, Choueiri, Toni K., additional, and Pal, Sumanta K., additional

Published
2020
Full Text
View/download PDF

12. Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of Cohort 6 of the COSMIC-021 Study.

Author

Agarwal, Neeraj, primary, Loriot, Yohann, additional, McGregor, Bradley Alexander, additional, Dreicer, Robert, additional, Dorff, Tanya B., additional, Maughan, Benjamin Louis, additional, Kelly, William Kevin, additional, Pagliaro, Lance C., additional, Srinivas, Sandy, additional, Squillante, Christian Michael, additional, Vaishampayan, Ulka N., additional, Liu, Yingjie, additional, Curran, Dominic, additional, Choueiri, Toni K., additional, and Pal, Sumanta K., additional

Published
2020
Full Text
View/download PDF

13. Insights on balancing short and long-term development

Author

Curran, Dominic

Subjects
Business, Business, international, High technology industry
Abstract

Abstract Consumer goods companies are focusing their efforts more and more on winning through innovation. Those not previously responsible for the innovation process are facing the dilemma of how to [...]

Published
1999

14. An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Author

Packiam, Vignesh T., primary, Lamm, Donald L., additional, Barocas, Daniel A., additional, Trainer, Andrew, additional, Fand, Benjamin, additional, Davis, Ronald L., additional, Clark, William, additional, Kroeger, Michael, additional, Dumbadze, Igor, additional, Chamie, Karim, additional, Kader, A. Karim, additional, Curran, Dominic, additional, Gutheil, John, additional, Kuan, Arthur, additional, Yeung, Alex W., additional, and Steinberg, Gary D., additional

Published
2018
Full Text
View/download PDF

17. An apathetic generation?

Author

Curran, Dominic

Abstract

The article looks at the efforts and developments of the British youth in promoting for political and social change. The youth protesters had been known for holding protests in 2010 against the plan of the British government to raise tuition fees and removal of the Educational Maintenance to cut government deficit. Youth support towards the British Labour Party declined due to lack of self-governing and membership capabilities of Young Labour, the youth wing of the party.

Published
2013

18. LETTERS.

Author

Birkby, Marianne, Curran, Dominic, Raybould, Paul, McKay, Ron, Agbor, G., and Hinnrichs, Alan

Abstract

Several letters to the editor are presented in response to articles in previous issues including the plan of building up a low-carbon energy policy in Great Britain, the implementation of a more market-oriented socialism under Deng Xiaoping, and the rally of the Tolpuddle Martyrs in Dorset, England.

Published
2010

19. LETTERS.

Author

Perry, Michael, Curran, Dominic, Latham, Peter, Gill, Joe, and Flett, Keith

Abstract

Several letters to the editor are presented in response to articles in previous issues including one by George Galloway on the positive developments in the U.S. in the June 20-21, 2009 issue, one from Peter Latham who appreciate the new layout and greater performance of this newspaper, and one by Mick Kenny who correctly points out in his article the Red Army's role in liberating Poland from the Nazis in 1945 in the June 17, 2009 issue.

Published
2009

20. Public has faith in LOCOG to deliver.

Author

Curran, Dominic

Subjects
SURVEYS, REPUTATION, OLYMPIC Games (30th : 2012 : London, England), SATISFACTION
Abstract

The article reports on the results of the reputation survey conducted by OnePoll regarding the 2012 Olympic Games that will be held in London, England. Majority of survey respondents expressed satisfaction with regard to the event preparations being done by the London Organising Committee of the Olympic Games and Paralympic Games (LOCOG). Most respondents consider ticket prices as expensive. The potential impact of the event to the reputation of London as a city is also evaluated.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results